Flibanserin for the treatment of urinary incontinence and related diseases
US10004731B2 · kind B2 · utility
0Cited by
56References
17Claims
0Family size
Inventors
Key dates
| Filing date | Aug 25, 2017 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Aug 25, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of Flibanserin for the treatment or prevention of urinary incontinence and related diseases. In a further embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment or prevention of urinary incontinence and related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.